Search Results - "Thuillet, Raphael"
-
1
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
Published in The Journal of clinical investigation (01-05-2018)“…Pulmonary arterial hypertension (PAH) is characterized by a progressive accumulation of pulmonary artery smooth muscle cells (PA-SMCs) in pulmonary arterioles…”
Get full text
Journal Article -
2
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension
Published in Circulation research (15-03-2019)“…RATIONALE:Although many familial cases of pulmonary arterial hypertension exhibit an autosomal dominant mode of inheritance with the majority having mutations…”
Get full text
Journal Article -
3
Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
Published in American journal of respiratory and critical care medicine (15-10-2015)“…Inflammation and endothelial dysfunction are considered two primary instigators of pulmonary arterial hypertension (PAH). CD74 is a receptor for the…”
Get full text
Journal Article -
4
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
Published in Cardiovascular research (01-03-2020)“…Abstract Aims The progressive accumulation of cells in pulmonary vascular walls is a key pathological feature of pulmonary arterial hypertension (PAH) that…”
Get full text
Journal Article -
5
Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension
Published in Circulation (New York, N.Y.) (15-04-2014)“…BACKGROUND—Pericytes and their crosstalk with endothelial cells are critical for the development of a functional microvasculature and vascular remodeling. It…”
Get full text
Journal Article -
6
Dasatinib increases endothelial permeability leading to pleural effusion
Published in The European respiratory journal (01-01-2018)“…Pleural effusion is a frequent side-effect of dasatinib, a second-generation tyrosine kinase inhibitor used in the treatment of chronic myelogenous leukaemia…”
Get full text
Journal Article -
7
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Published in The Journal of clinical investigation (01-09-2016)“…Pulmonary arterial hypertension (PAH) is a life-threatening disease that can be induced by dasatinib, a dual Src and BCR-ABL tyrosine kinase inhibitor that is…”
Get full text
Journal Article -
8
Serum and Pulmonary Uric Acid in Pulmonary Arterial Hypertension
Published in The European respiratory journal (01-08-2021)“…Earlier studies have suggested an association between uric acid (UA) and pulmonary arterial hypertension (PAH) severity, but it remains unknown whether UA…”
Get full text
Journal Article -
9
Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension
Published in Arteriosclerosis, thrombosis, and vascular biology (01-03-2020)“…OBJECTIVE:Excessive accumulation of resident cells within the pulmonary vascular wall represents the hallmark feature of the remodeling occurring in pulmonary…”
Get full text
Journal Article -
10
Effects of B Cell Depletion by CD19-Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-02-2024)“…Our goal was to study the tolerance and efficacy of two B cell depletion strategies, including one with CD19-targeted chimeric antigen receptor (CAR) T cells,…”
Get full text
Journal Article -
11
Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats
Published in Hypertension (Dallas, Tex. 1979) (01-10-2022)“…BACKGROUNDWe studied the ability of the nonsteroidal MR (mineralocorticoid receptor) antagonist finerenone to attenuate vascular remodeling and pulmonary…”
Get full text
Journal Article -
12
Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension
Published in Cardiovascular research (23-04-2021)“…Abstract Aims Although right ventricular (RV) function is an important determinant of morbidity and mortality in patients with pulmonary arterial hypertension…”
Get full text
Journal Article -
13
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
Published in Arthritis research & therapy (12-09-2023)“…Background Uncontrolled T-cell activation plays a key role in systemic sclerosis (SSc). Arsenic trioxide (ATO) has immunological effects and has demonstrated…”
Get full text
Journal Article -
14
Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension
Published in Chest (01-06-2016)“…Background Pulmonary arterial hypertension (PAH) encompasses a group of conditions with distinct causes. Immunologic disorders are common features of all forms…”
Get full text
Journal Article -
15
Leptin signalling system as a target for pulmonary arterial hypertension therapy
Published in The European respiratory journal (01-04-2015)“…Excessive proliferation of pulmonary arterial smooth muscle cells (PA-SMCs) and perivascular inflammation lead to pulmonary arterial hypertension (PAH)…”
Get full text
Journal Article -
16
AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery
Published in European journal of pharmacology (05-05-2023)“…Pulmonary hypertension (PH) is associated with pulmonary vasoconstriction and endothelial dysfunction leading to impaired nitric oxide (NO) and prostacyclin…”
Get full text
Journal Article -
17
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension
Published in Circulation (New York, N.Y.) (13-06-2023)“…Activins are novel therapeutic targets in pulmonary arterial hypertension (PAH). We therefore studied whether key members of the activin pathway could be used…”
Get full text
Journal Article -
18
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Published in Arthritis research & therapy (05-01-2022)“…Uncontrolled immune response with T cell activation has a key role in the pathogenesis of systemic sclerosis (SSc), a disorder that is characterized by…”
Get full text
Journal Article -
19
Driving Role of Interleukin‐2–Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic Sclerosis
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-08-2022)“…Objective Systemic sclerosis (SSc) is a debilitating autoimmune disease characterized by severe lung outcomes resulting in reduced life expectancy…”
Get full text
Journal Article -
20
Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension
Published in The Journal of heart and lung transplantation (01-01-2024)“…Leptin receptor (ObR-b) is overexpressed in pulmonary artery smooth muscle cells (PA-SMCs) from patients with pulmonary arterial hypertension (PAH) and is…”
Get full text
Journal Article